Skip to main content Accessibility help

Development and assessment of an improved recombinant multiepitope antigen-based immunoassay to diagnose chronic Chagas disease

  • Luz María Peverengo (a1), Valeria Garcia (a2), Luz María Rodeles (a1) (a3), Diego Mendicino (a4), Miguel Vicco (a3), Claudia Lagier (a5), Verónica Gonzalez (a2), Luis Gugliotta (a2) and Iván Marcipar (a1) (a3)...


The use of chimeric molecules fusing several antigenic determinants is a promising strategy for the development of low-cost, standardized and reliable kits to determine specific antibodies. In this study, we designed and assessed a novel recombinant chimera that complements the performance of our previously developed chimera, CP1 [FRA and SAPA antigens (Ags)], to diagnose chronic Chagas disease. The new chimeric protein, named CP3, is composed of MAP, TcD and TSSAII/V/VI antigenic determinants. We compared the performance of both chimeric Ags using a panel of 67 Trypanosoma cruzi-reactive sera and 67 non-reactive ones. The sensitivity of CP3 vs CP1 was 100 and 90.2%, and specificity was 92.5 and 100%, respectively. The mixture of CP1 + CP3 achieved 100% of sensitivity and specificity. More importantly, an additional subset of 17 sera from patients with discordant results of conventional serological methods was analysed; the CP1 + CP3 mixture allowed us to accurately classify 14 of them with respect to IIF, the usual technique used in most of the reference centres. These results show an improved performance of the CP1 + CP3 mixture in comparison with enzyme-linked immunosorbent assay and indirect haemagglutination commercial assays.


Corresponding author

Author for correspondence: Luz María Peverengo, E-mail:


Hide All
Aguirre, S, Silber, AM, Brito, MEF, Ribone, ME, Lagier, CM and Marcipar, IS (2006) Design, construction, and evaluation of a specific chimeric antigen to diagnose Chagasic infection. Journal of Clinical Microbiology 44, 37683774.
Bainor, A, Chang, L, McQuade, TJ, Webb, B and Gestwicki, JE (2011) Bicinchoninic acid (BCA) assay in low volume. Analytical Biochemistry 410, 310312.
Balouz, V, Cámara, MdLM, Cánepa, GE, Carmona, SJ, Volcovich, R, Gonzalez, N, Altcheh, J, Agüero, F and Buscaglia, CA (2015) Mapping antigenic motifs in the trypomastigote small surface antigen from Trypanosoma cruzi. Clinical and Vaccine Immunology: CVI 22, 304312.
Bhattacharyya, T, Brooks, J, Yeo, M, Carrasco, HJ, Lewis, MD, Llewellyn, MS and Miles, MA (2010) Analysis of molecular diversity of the Trypanosoma cruzi trypomastigote small surface antigen reveals novel epitopes, evidence of positive selection and potential implications for lineage-specific serology. International Journal for Parasitology 40, 921928.
Burgos, JM, Diez, M, Vigliano, C, Bisio, M, Risso, M, Duffy, T, Cura, C, Brusses, B, Favaloro, L, Leguizamon, MS, Lucero, RH, Laguens, R, Levin, MJ, Favaloro, R and Schijman, AG (2010) Molecular identification of Trypanosoma cruzi discrete typing units in end-stage chronic Chagas heart disease and reactivation after heart transplantation. Clinical Infectious Diseases 51, 485495.
Camussone, C, Gonzalez, V, Belluzo, MS, Pujato, N, Ribone, ME, Lagier, CM and Marcipar, IS (2009) Comparison of recombinant Trypanosoma cruzi peptide mixtures versus multiepitope chimeric proteins as sensitizing antigens for immunodiagnosis. Clinical and Vaccine Immunology: CVI 16, 899905.
Carvalho, MR, Krieger, MA, Almeida, E, Oelemann, W, Shikanai-Yassuda, MA, Ferreira, AW, Pereira, JB, Sáez-Alquézar, A, Dorlhiac-Llacer, PE and Chamone, DF (1993) Chagas’ disease diagnosis: evaluation of several tests in blood bank screening. Transfusion 33, 830834.
Cimino, RO, Rumi, MM, Ragone, P, Lauthier, J, Alberti D’ Amato, A, Quiroga, IRL, Gil, JF, Cajal, SP, Acosta, N, Juárez, M, Krolewiecki, A, Orellana, V, Zacca, R, Marcipar, I, Diosque, P and Nasser, JR (2011) Immuno-enzymatic evaluation of the recombinant TSSA-II protein of Trypanosoma cruzi in dogs and human sera: a tool for epidemiological studies. Parasitology 138, 9951002.
da Silveira, JF, Umezawa, ES and Luquetti, AO (2001) Chagas disease: recombinant Trypanosoma cruzi antigens for serological diagnosis. Trends in Parasitology 17, 286291.
De Marchi, CR, Di Noia, JM, Frasch, ACC, Amato Neto, V, Almeida, IC and Buscaglia, CA (2011) Evaluation of a recombinant Trypanosoma cruzi mucin-like antigen for serodiagnosis of Chagas’ disease. Clinical and Vaccine Immunology: CVI 18, 18501855.
Di Noia, JM, Buscaglia, CA, De Marchi, CR, Almeida, IC and Frasch, ACC (2002) A Trypanosoma cruzi small surface molecule provides the first immunological evidence that Chagas’ disease is due to a single parasite lineage. The Journal of Experimental Medicine 195, 401413.
Granjon, E, Dichtel-Danjoy, M-L, Saba, E, Sabino, E, Campos de Oliveira, L and Zrein, M (2016) Development of a novel multiplex immunoassay multi-cruzi for the serological confirmation of Chagas disease. PLoS Neglected Tropical Diseases 10, e0004596.
Houghton, RL, Benson, DR, Reynolds, LD, McNeill, PD, Sleath, PR, Lodes, MJ, Skeiky, YAW, Leiby, DA, Badaro, R and Reed, SG (1999) A multi-epitope synthetic peptide and recombinant protein for the detection of antibodies to Trypanosoma cruzi in radioimmunoprecipitation-confirmed and consensus-positive sera. The Journal of Infectious Diseases 179, 12261234.
Houghton, RL, Benson, DR, Reynolds, L, McNeill, P, Sleath, P, Lodes, M, Skeiky, YAW, Badaro, R, Krettli, AU and Reed, SG (2000) Multiepitope synthetic peptide and recombinant protein for the detection of antibodies to Trypanosoma cruzi in patients with treated or untreated Chagas’ disease. The Journal of Infectious Diseases 181, 325330.
Laemmli, UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680685.
Marcipar, IS and Lagier, CM (2012) Advances in serological diagnosis of Chagas' disease by using recombinant proteins. In Rodriguez-Morales, Alfonso J. (ed.), Current Topics in Tropical Medicine. Rijeka, Croatia: InTech, pp. 273298. doi: 10.5772/28100.
Ministerio de Salud de la Nación Argentina (2012) Guías para la atención al paciente infectado con Trypanosoma cruzi (Enfermedad de Chagas). Available online at
Moure, Z, Angheben, A, Molina, I, Gobbi, F, Espasa, M, Anselmi, M, Salvador, F, Tais, S, Sánchez-Montalvá, A, Pumarola, T, Albajar-Viñas, P and Sulleiro, E (2016) Serodiscordance in chronic Chagas disease diagnosis: a real problem in non-endemic countries. Clinical Microbiology and Infection 22, 788792.
National Institutes of Health (2016) NCI Best Practices for Biospecimen Resources. Available online at
Oelemann, WM, Vanderborght, BO, Verissimo Da Costa, GC, Teixeira, MG, Borges-Pereira, J, De Castro, JA, Coura, JR, Stoops, E, Hulstaert, F, Zrein, M and Peralta, JM (1999) A recombinant peptide antigen line immunoassay optimized for the confirmation of Chagas’ disease. Transfusion 39, 711717.
Praast, G, Herzogenrath, J, Bernhardt, S, Christ, H and Sickinger, E (2011) Evaluation of the Abbott ARCHITECT Chagas prototype assay. Diagnostic Microbiology and Infectious Disease 69, 7481.
Santos, FLN, Celedon, PAF, Zanchin, NIT, Souza, WV, de Silva, ED, da Foti, L, Krieger, MA and Gomes, YdM (2017) Accuracy of chimeric proteins in the serological diagnosis of chronic Chagas disease – a phase II study. PLoS Neglected Tropical Diseases 11, e0005433.
Umezawa, ES, Bastos, SF, Coura, JR, Levin, MJ, Gonzalez, A, Rangel-Aldao, R, Zingales, B, Luquetti, AO and da Silveira, JF (2003) An improved serodiagnostic test for Chagas’ disease employing a mixture of Trypanosoma cruzi recombinant antigens. Transfusion 43, 9197.
World Health Organization (2002) Control of Chagas disease: second report of the WHO expert committee. Geneva: WHO.
World Health Organization (2010) Report 1. Anti-Trypanosoma cruzi Assays Operational Characteristics. Geneva: WHO.
World Health Organization (2015) Weekly epidemiological record Relevé épidémiologique hebdomadaire. Geneva: WHO.



Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed